BofA Global Research raises Ares Management price objective to $164 from $156
ARES•BofA Global Research raised its price objective for Ares Management to $164 from $156.
Related News
Emerson: Morgan Stanley cuts target price to $140 from $145
EMR•
BTIG cuts Bright Minds Biosciences target price to $37 from $147
DRUG•
Lumentum target price cut to $685 from $820 by TD Cowen
LITE•
StepStone Group target price cut to $72 from $73 by J.P. Morgan
STEP•
JPMorgan raises Tempus AI target price to $80 from $70
TEM•